Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Other Working Capital Changes (2022 - 2025)

Bioregenx's Other Working Capital Changes history spans 4 years, with the latest figure at -$18986.0 for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$18986.0 for Q4 2025, up 63.91% from a year ago — trailing twelve months through Dec 2025 was -$88073.0 (up 34.75% YoY), and the annual figure for FY2025 was -$88073.0, up 34.75%.
  • Other Working Capital Changes for Q4 2025 was -$18986.0 at Bioregenx, down from $6446.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $131096.0 in Q3 2023 to a low of -$139001.0 in Q2 2024.
  • The 4-year median for Other Working Capital Changes is -$2667.0 (2022), against an average of -$6497.2.
  • The sharpest move saw Other Working Capital Changes soared 5017.33% in 2023, then crashed 2288.83% in 2025.
  • Year by year, Other Working Capital Changes stood at -$2667.0 in 2022, then crashed by 2287.81% to -$63683.0 in 2023, then rose by 17.38% to -$52614.0 in 2024, then skyrocketed by 63.91% to -$18986.0 in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$18986.0, $6446.0, and -$11269.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.